Question 1

What is Spruce Biosciences's P/S ratio?

Accepted Answer

Spruce Biosciences (SPRB) P/S ratio is 45.1× as of March 6, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for Spruce Biosciences?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For Spruce Biosciences specifically, the relevant sector benchmark is the current sector median of 3.7×.

Question 5

Is Spruce Biosciences's P/S ratio high or low?

Accepted Answer

Spruce Biosciences's P/S ratio of 45.1× is above its own 5-year average of 9.6× and above the sector median of 3.7×. That places the current reading at the 86th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Spruce Biosciences's historical P/S ratio range?

Accepted Answer

In the available daily series, Spruce Biosciences (SPRB) P/S ratio has ranged from a low of 0.6× in 2025 to a high of 93.4× in 2025. The 5-year average is 9.6× and the 5-year median is 4.3×.

Question 7

What was Spruce Biosciences's P/S ratio in 2024?

Accepted Answer

Spruce Biosciences (SPRB) P/S ratio at the end of 2024 was 3.4×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does Spruce Biosciences's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$66.78M	$0.00	—	—	Dec 31, 2025
2024	$16.90M	$4.91M	3.4×	-8.2×	Dec 31, 2024
2023	$117.21M	$10.09M	11.6×	—	Dec 31, 2023
2022	$50.41M	$0.00	—	—	Dec 31, 2022
2021	$203.98M	$0.00	—	—	Dec 31, 2021
2020	$1.10B	$0.00	—	—	Dec 31, 2020
2019	$754.56M	$0.00	—	—	Dec 31, 2019


AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
UnitedHealth Group (UNH)	0.5×
Teladoc Health (TDOC)	0.4×
Elevance Health (ELV)	0.3×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Molina Healthcare (MOH)	0.2×
Centene (CNC)	0.1×

P/S Ratio for Spruce Biosciences (SPRB)

P/S Ratio daily chart for Spruce Biosciences (SPRB)

Historical P/S Ratio for Spruce Biosciences (SPRB) from 2019 to 2025

About P/S Ratio at Spruce Biosciences (SPRB)

Spruce Biosciences P/S Ratio by Year

Spruce Biosciences P/S Ratio 2024: 3.4×

Spruce Biosciences P/S Ratio 2023: 11.6×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

Spruce Biosciences (SPRB) Key Financials

P/S Ratio daily chart for Spruce Biosciences (SPRB)

Historical P/S Ratio for Spruce Biosciences (SPRB) from 2019 to 2025

About P/S Ratio at Spruce Biosciences (SPRB)

Spruce Biosciences P/S Ratio by Year

Spruce Biosciences P/S Ratio 2024: 3.4×

Spruce Biosciences P/S Ratio 2023: 11.6×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

+What is Spruce Biosciences's P/S ratio?

+How is the P/S ratio calculated?

+What is the P/S ratio?

+What is a good P/S ratio for Spruce Biosciences?

+Is Spruce Biosciences's P/S ratio high or low?

+What is Spruce Biosciences's historical P/S ratio range?

+What was Spruce Biosciences's P/S ratio in 2024?

+Why does Spruce Biosciences's P/S ratio change over time?

Spruce Biosciences (SPRB) Key Financials